A conceptually new model for the development and progression of multiple myeloma has been presented by researchers from Uppsala University. Myeloma is one of the most common blood cancers, and at present considered to be incurable.
Using large cohorts of myeloma patients, the researchers have identified a profile of genes that are silenced by epigenetic mechanisms in the malignant plasma cell.
Multiple Myeloma
Multiple Myeloma caught public attention when model turned actress Lisa Ray, who worked in Deepa Mehta's 'Water' , declared that she had the incurable Multiple Myeloma.
Advertisement
"This silencing may lead to the uncontrolled growth of the malignant cells," said Helena Jernberg Wiklund, one of the investigators in the study.
The silenced gene profile was compared and contrasted to normal plasma cells, which are highly specialised and for which growth and lifetime is tightly controlled.
![Leukemia]( "Leukemia")
The silenced genes have a common denominator in being targets and controlled by the Polycomb repressor complex (PcG).
This complex has previously been implicated in self-renewal and division of normal embryonic stem cells.
In the study, the researchers found that inhibitors of PcG also could decrease the growth of tumour cells in an animal model of myeloma.
"A new strategy for treating multiple myeloma could be to develop drugs that are targeted to the PcG complex, leading to reactivation of the silenced gene profile", said Helena Jernberg Wiklund.
The study is published in the latest edition of the on-line journal PLoS ONE.
Source: ANI
Advertisement
The silenced genes have a common denominator in being targets and controlled by the Polycomb repressor complex (PcG).
This complex has previously been implicated in self-renewal and division of normal embryonic stem cells.
In the study, the researchers found that inhibitors of PcG also could decrease the growth of tumour cells in an animal model of myeloma.
"A new strategy for treating multiple myeloma could be to develop drugs that are targeted to the PcG complex, leading to reactivation of the silenced gene profile", said Helena Jernberg Wiklund.
The study is published in the latest edition of the on-line journal PLoS ONE.
Source: ANI
Acute Lymphoblastic Leukemia
Acute lymphoblastic leukemia (ALL) is the cancer of white blood cells characterized by excess lymphoblasts. It is the most common of all childhood cancers and can be fatal in weeks if left untreated.
Advertisement
 Acute Myeloid LeukemiaAcute myeloid Leukemia, more popularly known by its abbreviated form AML, is a fast- evolving leukemia that affects both children and adults alike | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable
A ray of hope for glioma patients as targeted therapy boosts treatment duration.